1. O'Brien WM. Pharmacology of nonsteroidal anti-inflammatory drugs. Practical review for clinicians. Am J Med. 1983;75(4B):32-39.
2. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082-2097.
3. 中国医师协会神经内科医师分会,中国研究型医院学会头痛与感觉障碍专业委员会. 中国偏头痛诊治指南(2022版)[J]. 中国疼痛医学杂志,2022,28(12):881-898.
4. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015;2015(7):CD001751.
5. Volkow ND, McLellan AT. Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies. N Engl J Med. 2016;374(13):1253-1263.
6. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020 ;180:114147.
7. Vittinghoff M, Lönnqvist PA, Mossetti V, et al. Postoperative pain management in children: Guidance from the pain committee of the European Society for Paediatric Anaesthesiology (ESPA Pain Management Ladder Initiative). Paediatr Anaesth. 2018;28(6):493-506. WILLIAMS A C, CRAIG K D. Updating the definition of pain [J]. Pain, 2016, 157(11): 2420-2423.
8. van den Beuken-van Everdingen MH, Hochstenback LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer:systematic review and meta-analysis. J Pain Symptom Manage. 2016,51(6):1070–1090.
9. 中国《癌症疼痛诊疗规范》2018年版
10. 郭素萍,武艳阳.规范化止痛治疗对癌痛患者心理痛苦的影响[J].中华现代护理杂志,2013,48(32):3975-3978.
11. Kroenke K, Theobald D, Wu J, et al. The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage 2010,40(3):327-341.
12. 黄英,汪红英,洪洁等.癌痛患者自杀风险因素及心理干预应用的研究进展[J].实用临床医学,2017,18(7):104-107.
13. 苏翔宇,高潺潺,侍方方,周良,王彩莲.阿片类药物治疗中重度癌痛病人的营养状况及影响因素分析[J].肠外与肠内营养,2019,26(05):261-265.
14. NCCN Clinical Practice Guidelines in Oncology. Adult Cancer Pain. Version 1.2020.